Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
- 4 May 2009
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 35 (5), 463-474
- https://doi.org/10.1016/j.ctrv.2009.03.004
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized TrialClinical Cancer Research, 2008
- Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscopeBritish Journal of Cancer, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissuesProceedings of the National Academy of Sciences, 2006
- Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancerJournal of Clinical Pathology, 2006
- Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000